Pulmonary Hypertension

January 5, 2016January 6, 2016

LARIAT Clinical Trial Opens to Pulmonary Hypertension Patients with ILD

Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company based in Irving, Texas, recently announced that it has enrolled the first patient with pulmonary hypertension associated with interstitial lung disease (PH-ILD) in ... Read more

December 16, 2015December 16, 2015

Eiger BioPharmaceuticals Submits New Patent for Pulmonary Arterial Hypertension (PAH) Treatment

News, Pulmonary Hypertension

Eiger BioPharmaceuticals, Inc. recently announced the filing of a new patent for a novel PAH therapy. The company’s new “Treatment of Pulmonary Hypertension with Leukotriene Inhibitors” patent is designed to cover Bestatin™ (ubenimex), ... Read more

December 11, 2015December 11, 2015

Pulmonary Cell Proliferation in PAH Triggered by RNA Fragments

News, Pulmonary Hypertension

In pulmonary hypertension, vascular remodeling due to excessive proliferation of endothelial and smooth muscle cells is a hallmark feature. Now, researchers have identified miR-125a as an important player in that remodeling. ... Read more

December 8, 2015December 8, 2015

PAH Therapy with Preservative-free Trevyent Shows Promise in Easing Pain

News, Pulmonary Hypertension

SteadyMed Ltd., a pharmaceutical company focused on developing drugs for the treatment of orphan and high value diseases, has announced positive data from an animal study assessing the clinical effects of its Trevyent® (preservative-free ... Read more

December 8, 2015December 8, 2015

COPD Patients with Pulmonary Hypertension at Risk of Complications in FB

News, Pulmonary Hypertension

A recent study of an endoscopic technique called flexible bronchoscopy (FB) in patients with chronic obstructive pulmonary disease (COPD) and pulmonary hypertension (PH) has found these patients have an elevated risk of lower blood-oxygen levels than COPD ... Read more

December 7, 2015December 7, 2015

Inoperable CTEPH Patients At Risk of Heart Failure May be Identified by Serum Bilirubin, 6-min Walk Distance Levels

News, Pulmonary Hypertension

In a new study entitled “Serum Bilirubin and 6-min Walk Distance as Prognostic Predictors for Inoperable Chronic Thromboembolic Pulmonary Hypertension: A Prospective Cohort Study,” researchers found that serum total bilirubin ... Read more

December 4, 2015December 4, 2015

PAH Patients in Ontario Want Opsumit in Public Drug Plan

News, Pulmonary Hypertension

Canadians living with pulmonary arterial hypertension (PAH) — a rare, progressive lung disease — gathered at Queen’s Park in Ontario recently to urge their province’s health minister, Dr. Eric Hoskins, to publicly ... Read more

December 2, 2015December 2, 2015

COPD, Pulmonary Hypertension May Be Best Assessed by Chest Scan

News, Pulmonary Hypertension

Chest computed tomography could be a simple and useful method for diagnostic evaluation of COPD and pulmonary hypertension, according to a new study, “Computed tomography measurement of pulmonary artery for diagnosis ... Read more

November 25, 2015May 12, 2016

Bayer Survey Finds Doctors Ill-informed of a Chronic Lung Disease

News, Pulmonary Hypertension

A recent survey found that many primary care physicians are unfamiliar with chronic thromboembolic pulmonary hypertension (CTEPH) and slow to refer CTEPH patients to specialists, although the disease is treatable and potentially curable. The ... Read more

November 18, 2015

Pre- and Post-capillary PH Distinguished Through New Research That Gauges Hemodynamic Variables

News, Pulmonary Hypertension

In a new study, researchers from the Vienna General Hospital, Medical University of Vienna and collaborators have identified hemodynamic variables that are essential for the differentiation between pulmonary arterial hypertension ... Read more